StonvexLoading…
StonvexStonvexStonvexCore line items from CBAN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $149.95M | $137.24M | $124.92M | $91.54M |
Operating Income | $35.13M | $29.57M | $27.21M | $22.85M |
Net Income | $28.25M | $23.87M | $21.75M | $19.54M |
EPS (Diluted) | $1.59 | $1.36 | $1.24 | $1.14 |
Total Assets | $3.74B | $3.11B | $3.05B | $2.94B |
Total Liabilities | $3.36B | $2.83B | $2.80B | $2.71B |
Cash & Equivalents | $257.64M | $231.03M | $83.32M | $80.68M |
Free Cash Flow OCF − CapEx | $-6.90M | $22.32M | $17.36M | $46.85M |
Shares Outstanding | 21.25M | 17.52M | 17.56M | 17.60M |